1-175079594-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_022093.2(TNN):āc.671T>Cā(p.Met224Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000245 in 1,594,312 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_022093.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNN | NM_022093.2 | c.671T>C | p.Met224Thr | missense_variant | 3/19 | ENST00000239462.9 | NP_071376.1 | |
TNN | XM_017002048.2 | c.725T>C | p.Met242Thr | missense_variant | 3/19 | XP_016857537.1 | ||
TNN | XM_017002049.2 | c.725T>C | p.Met242Thr | missense_variant | 3/18 | XP_016857538.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNN | ENST00000239462.9 | c.671T>C | p.Met224Thr | missense_variant | 3/19 | 2 | NM_022093.2 | ENSP00000239462 | P1 | |
TNN | ENST00000621086.1 | c.671T>C | p.Met224Thr | missense_variant | 2/16 | 5 | ENSP00000480895 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152144Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000336 AC: 7AN: 208250Hom.: 0 AF XY: 0.0000175 AC XY: 2AN XY: 114306
GnomAD4 exome AF: 0.0000159 AC: 23AN: 1442168Hom.: 0 Cov.: 32 AF XY: 0.0000126 AC XY: 9AN XY: 716124
GnomAD4 genome AF: 0.000105 AC: 16AN: 152144Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74312
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at